Baxter Healthcare

Cefepime HCL

Manufacturer:

Baxter Healthcare

Cefepime Hcl HCPCS:

J0701

HCPCS Code Descriptor:

Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg

Category:

J Code

Cefepime Hcl NDCs:

00338-1301-48, 00338-1301-41

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Bag

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00338-1301-48, 00338-1301-41

About Cefepime Hcl:

Cefepime HCL is an Antibiotic drug manufactured by Baxter Healthcare and administered via the Intravenous route of administration. The J Code: J0701 is aligned to the drug Cefepime HCL.

ACCESS PRICING AND MORE BY REGISTERING

J0701 Added Date:

January 1, 2023

J0701 Effective Date:

January 1, 2023

J0701 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cefepime Hcl billing and coding information.
Our team did not identify a source for Cefepime Hcl patient assistance information. Please reach out to our team if you feel that this is a mistake.
Cefepime HCL prescribing information can be found at the link below:
Information regarding Cefepime HCL’s side effects can be found at MedlinePlus